Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Liked2Thinkon Jun 17, 2021 3:23pm
129 Views
Post# 33405666

RE:RE:RE:New post on facebook

RE:RE:RE:New post on facebookso now they have 5000 clients and not 10,000.

Care just seems like some pill pushers to me now.  No wonder they arent bigger.  Hard to convince people that some drugs can help with cancer when its not main stream.

I dont care what the numbers are i just want to know what they truely are.

1,000 test per day capacity for covid - how many do we average a day now
how many aristotle tests have been completed since product released
how many clients does Care currently have? do they make money, how much debt do they have.  I dont want this in some interview that I have to believe what is being said i want it is reported data.
if Care works out of canada why hasnt Ichor started aristotle.  At least we know Ichor gets things done.

i look forward to the next quarterly report when we can hear how "exciting" things are again with no proof except for record low SP value. 
<< Previous
Bullboard Posts
Next >>